My background is a buy-side equity trader for 28 years. There are complexity levels of investment products. Screening should be increased as the complexity levels increase, such as the Option trading approval levels are done. There are some newer products like inverse leveraged, and multiplied leveraged ETFs that normal investors do not understand. Specifically the use of futures and options and the declining time value of the instruments. This comes into play during a roll of the instrument to the next expiry. No wonder firms like Vanguard already halted new purchases of these faulty products.
For the Public
FINRA DATA
FINRA Data provides non-commercial use of data, specifically the ability to save data views and create and manage a Bond Watchlist.
For Industry Professionals
FINPRO
Registered representatives can fulfill Continuing Education requirements, view their industry CRD record and perform other compliance tasks.
For Member Firms
FINRA GATEWAY
Firm compliance professionals can access filings and requests, run reports and submit support tickets.
For Case Participants
DR PORTAL
Arbitration and mediation case participants and FINRA neutrals can view case information and submit documents through this Dispute Resolution Portal.
Need Help? | Check System Status
Log In to other FINRA systems
Anonymous Comment On Regulatory Notice 22-08
My background is a buy-side equity trader for 28 years. There are complexity levels of investment products. Screening should be increased as the complexity levels increase, such as the Option trading approval levels are done. There are some newer products like inverse leveraged, and multiplied leveraged ETFs that normal investors do not understand. Specifically the use of futures and options and the declining time value of the instruments. This comes into play during a roll of the instrument to the next expiry. No wonder firms like Vanguard already halted new purchases of these faulty products.